As of Jul 31
| +0.40 / +0.35%|
The 5 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 135.00, with a high estimate of 151.00 and a low estimate of 101.07. The median estimate represents a +17.89% increase from the last price of 114.51.
The current consensus among 5 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.